21214-11-9 Usage
Uses
Used in Pharmaceutical Industry:
3-Dihydrobenzofuran-2-yl)Methanamine is used as a compound in the synthesis of pharmaceutical agents due to its aromatic properties and the versatile biological activities associated with benzofuran compounds. Its presence in natural products and potential for pharmaceutical applications make it a valuable component in drug development.
Used in Drug Discovery:
3-Dihydrobenzofuran-2-yl)Methanamine is used as a starting material or intermediate in drug discovery for its potential to contribute to the development of new therapeutic agents. 3-dihydrobenzofuran-2-yl)MethanaMine's structure and the biological activities of related benzofuran compounds suggest that it may have properties that could be harnessed for medicinal purposes.
Used in Chemical Research:
3-Dihydrobenzofuran-2-yl)Methanamine is used as a subject of chemical research to explore its properties, reactivity, and potential applications in various fields. As a less extensively studied or novel compound, it offers opportunities for scientists to investigate its behavior and interactions with other molecules, which could lead to new insights and applications.
Check Digit Verification of cas no
The CAS Registry Mumber 21214-11-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,1,2,1 and 4 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 21214-11:
(7*2)+(6*1)+(5*2)+(4*1)+(3*4)+(2*1)+(1*1)=49
49 % 10 = 9
So 21214-11-9 is a valid CAS Registry Number.
21214-11-9Relevant academic research and scientific papers
Design, synthesis and cytotoxic activities of novel hybrid compounds between dihydrobenzofuran and imidazole
Chen, Wen,Yang, Xiao-Dong,Li, Yan,Yang, Li-Juan,Wang, Xue-Quan,Zhang, Gao-Lan,Zhang, Hong-Bin
, p. 4250 - 4255 (2011/07/29)
A series of novel hybrid compounds between dihydrobenzofuran and imidazole has been prepared and evaluated in vitro against a panel of human tumor cell lines. The results suggest that substitution of the imidazolyl-1-position with an electron-donating dihydrobenzofuran, and the imidazolyl-3-position with a naphthylacyl or electron-rich phenacyl group, were vital for modulating cytotoxic activity.
Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor and uses thereof
-
Page/Page column 19, (2008/06/13)
Compounds that are antagonists of the VR1 receptor, having formula (I) [image] or a pharmaceutically acceptable salt, prodrug, or salt of a prodrug thereof, wherein A1, A2, A3, A4, R7, R8, R9, X, Y, Z, L, n, and m, are as defined herein, and are useful in disorders prevented or ameliorated by inhibiting the VR1 receptor.
